160 related articles for article (PubMed ID: 11333899)
1. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
Bishop KN; Bock M; Towers G; Stoye JP
J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
[TBL] [Abstract][Full Text] [Related]
3. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
Kozak CA; Chakraborti A
Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
[TBL] [Abstract][Full Text] [Related]
4. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.
Aagaard L; Mikkelsen JG; Warming S; Duch M; Pedersen FS
J Gen Virol; 2002 Feb; 83(Pt 2):439-442. PubMed ID: 11807237
[TBL] [Abstract][Full Text] [Related]
5. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
6. Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions.
Lassaux A; Sitbon M; Battini JL
J Virol; 2005 May; 79(10):6560-4. PubMed ID: 15858043
[TBL] [Abstract][Full Text] [Related]
7. The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein.
Portis JL; Fujisawa R; Mcatee FJ
Virology; 1996 Dec; 226(2):384-92. PubMed ID: 8955058
[TBL] [Abstract][Full Text] [Related]
8. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
9. A conserved mechanism of retrovirus restriction in mammals.
Towers G; Bock M; Martin S; Takeuchi Y; Stoye JP; Danos O
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12295-9. PubMed ID: 11027299
[TBL] [Abstract][Full Text] [Related]
10. Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein.
McDermott J; Karanjia S; Love Z; Barklis E
Virology; 2000 Mar; 269(1):190-200. PubMed ID: 10725211
[TBL] [Abstract][Full Text] [Related]
11. Retroviral capsid determinants of Fv1 NB and NR tropism.
Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
[TBL] [Abstract][Full Text] [Related]
12. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
13. Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins.
Taylor WR; Stoye JP
BMC Struct Biol; 2004 Jan; 4():1. PubMed ID: 14715087
[TBL] [Abstract][Full Text] [Related]
14. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
15. Operating under a Gag order: a block against incoming virus by the Fv1 gene.
Goff SP
Cell; 1996 Sep; 86(5):691-3. PubMed ID: 8797814
[No Abstract] [Full Text] [Related]
16. Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.
Bamunusinghe D; Liu Q; Plishka R; Dolan MA; Skorski M; Oler AJ; Yedavalli VRK; Buckler-White A; Hartley JW; Kozak CA
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794032
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of Fv1: effects on retroviral restriction specificities.
Li W; Yap MW; Voss V; Stoye JP
Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of Ref1 retrovirus restriction in human cells.
Towers G; Collins M; Takeuchi Y
J Virol; 2002 Mar; 76(5):2548-50. PubMed ID: 11836433
[TBL] [Abstract][Full Text] [Related]
19. Use of a transient assay for studying the genetic determinants of Fv1 restriction.
Bock M; Bishop KN; Towers G; Stoye JP
J Virol; 2000 Aug; 74(16):7422-30. PubMed ID: 10906195
[TBL] [Abstract][Full Text] [Related]
20. Positional cloning of the mouse retrovirus restriction gene Fv1.
Best S; Le Tissier P; Towers G; Stoye JP
Nature; 1996 Aug; 382(6594):826-9. PubMed ID: 8752279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]